Lataa...
rhIGF-1 Therapy for Growth Failure and IGF-1 Deficiency in Congenital Disorder of Glycosylation Ia (PMM2 Deficiency)
Background. Congenital disorders of glycosylation (CDG) are a group of rare disorders in which glycosylation required for proper protein-protein interactions and protein stability is disrupted, manifesting clinically with multiple system involvement and growth failure. The insulin-like growth factor...
Tallennettuna:
| Julkaisussa: | J Investig Med High Impact Case Rep |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4586814/ https://ncbi.nlm.nih.gov/pubmed/26425584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2324709613503316 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|